| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/18/2000 | US6015876 Treating medical and laboratory equipment and supplies, suspensions, solutions, blood, blood products, and tissues by contacting with viricidal protein, peptide, or conjugate |
| 01/18/2000 | US6015832 Methods of inactivating bacteria including bacterial spores |
| 01/18/2000 | US6015825 Triazole antifungal agents |
| 01/18/2000 | US6015816 Attaching an antimicrobial ligand to clay in excess of the cationic exchange capacity, thereby imparting increased antimicrobial activity,controlling microbial growth on a material |
| 01/18/2000 | US6015810 Aqueous ophthalmic solution containing apafant as active ingredient |
| 01/18/2000 | US6015568 Anhydrous stable retinol based cosmetic or pharmaceutical composition |
| 01/18/2000 | US6015564 Polypeptides with fatty acid and steroids |
| 01/18/2000 | US6015562 Antitumor agents |
| 01/18/2000 | US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/18/2000 | US6015551 Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 01/18/2000 | US6015547 Zinc ion with anions for solutions |
| 01/18/2000 | US6015546 Atomizing a solution or dispersion of protein wall forming material |
| 01/18/2000 | US6015541 Radioactive embolizing compositions |
| 01/18/2000 | CA2027977C Arylsulfatase |
| 01/18/2000 | CA2013474C Cyclophosphamide - alanine lyophilizates |
| 01/18/2000 | CA2004049C Topical application of medicament in a binder |
| 01/14/2000 | WO2000003736A1 Prostaglandin product |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001851A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | WO2000001734A1 Linear cyclodextrin copolymers |
| 01/13/2000 | WO2000001419A1 Drug complex for treatment of metastatic prostate cancer |
| 01/13/2000 | WO2000001417A1 Delivery system |
| 01/13/2000 | WO2000001393A2 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 01/13/2000 | WO2000001390A1 Topical aciclovir formulations |
| 01/13/2000 | WO2000001384A1 Ketotifen preparation for percutaneous absorption |
| 01/13/2000 | WO2000001374A1 Therapeutic system with addition of nacreous pigments |
| 01/13/2000 | WO2000001369A1 Sustained release pharmaceutical preparation |
| 01/13/2000 | WO2000001366A1 A method of administering liposomal encapsulated taxane |
| 01/13/2000 | WO2000001351A1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 01/13/2000 | WO2000001321A1 Methods and compositions for producing a cooling effect in tissues |
| 01/13/2000 | WO1999060148A3 Display of viral proteins as ligands for cell-surface receptor |
| 01/13/2000 | WO1999055353A3 Protein formulations |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | WO1999036104A3 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 01/13/2000 | WO1999030745A3 Dota-biotin derivatives |
| 01/13/2000 | DE19830732A1 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff A composition comprising at least one lipid levels influencing drug |
| 01/13/2000 | DE19830651A1 Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung Steroid-containing patch, process for its preparation and use |
| 01/13/2000 | DE19830649A1 Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe The topical patch with NSAIDs with acid group |
| 01/13/2000 | DE19830648A1 Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung Glyceroltrinitrathaltige composition, process for their preparation and their use |
| 01/13/2000 | DE19830246A1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336384A1 Oligonucleotide inhibitors of bcl-xl |
| 01/13/2000 | CA2335824A1 Therapeutic system with addition of nacreous pigments |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | CA2303094A1 Methods and compositions for producing a cooling effect in tissues |
| 01/12/2000 | EP0970998A1 Wax ester of vaseline-like consistency |
| 01/12/2000 | EP0970705A1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both |
| 01/12/2000 | EP0970704A1 Silicone core long term androgen delivery implant |
| 01/12/2000 | EP0970703A1 Stable, aqueous alfa interferon solution formulations |
| 01/12/2000 | EP0970682A2 Water-in-oil composition with a variable shear rate |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0970114A1 Neoglycoproteins |
| 01/12/2000 | EP0970107A1 Cyclosporine derivatives and uses thereof |
| 01/12/2000 | EP0969874A1 Pharmaceutical compositions containing propanamine derivatives and cyclodextrin |
| 01/12/2000 | EP0969873A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/12/2000 | EP0969872A2 Induction of b cell tolerance |
| 01/12/2000 | EP0969871A1 Homogenous water-free formulations containing glycerophospholipids and polar or lipophilic substances, method for the production thereof |
| 01/12/2000 | EP0969860A1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer |
| 01/12/2000 | EP0969857A1 Pharmaceutical compositions |
| 01/12/2000 | EP0969856A1 Hydrophilic binary systems for the administration of cyclosporine |
| 01/12/2000 | EP0969846A1 Compositions and methods for reducing ocular hypertension |
| 01/12/2000 | EP0969832A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates |
| 01/12/2000 | EP0969831A1 Nasal melatonin composition |
| 01/12/2000 | EP0969825A1 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium |
| 01/12/2000 | EP0969821A1 Pellets having a core coated with an antifungal and a polymer |
| 01/12/2000 | EP0969817A1 Dosage forms having improved release properties |
| 01/12/2000 | EP0969816A1 Preparation of powder agglomerates |
| 01/12/2000 | EP0969815A2 Pharmaceutical compositions |
| 01/12/2000 | EP0969814A1 Opthalmic non-irritating iodine medicament and method |
| 01/12/2000 | EP0969813A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 01/12/2000 | EP0969812A1 Ophthalmic compositions including glycerin and propylene glycol |
| 01/12/2000 | EP0969807A2 Chitosane microspheres |
| 01/12/2000 | EP0969806A1 Keratotic plug remover |
| 01/12/2000 | EP0969742A2 Oral compositions having enhanced mouthfeel |
| 01/12/2000 | EP0778785B1 Methods and apparatus for the delivery of solid drug compositions |
| 01/12/2000 | CN1240646A Injectable composition of non-steroidal anti-inflammatory drugs |
| 01/11/2000 | US6013773 Pharmaceutical preparation containing human growth hormone |
| 01/11/2000 | US6013679 Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| 01/11/2000 | US6013665 Administering to a animal a triglyceride containg atleast 33 to 70 weight% medium acyl chain having 4 to 12 carbon atom, 30 to 67 weight % long acyl chain having more than 12 carbon atom, an equivalent carbon number 30 to 48 |
| 01/11/2000 | US6013657 Pharmaceutical compositions containing mupirocin |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013640 Antiischemic agents |
| 01/11/2000 | US6013636 Mixture with vegetable oil and cosolvent |
| 01/11/2000 | US6013635 Treatment of C. difficile toxin B associated conditions |
| 01/11/2000 | US6013632 Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or n-acetyl-l-cysteine, with or without antioxidants |
| 01/11/2000 | US6013619 Applying gas positive end-expiratory pressure with ventilator into lung section of mammal, instilling lavage composition containing dilute surfactant in a pharmaceutically acceptable aqueous medium into lung, removing pulmonary fluid |
| 01/11/2000 | US6013526 Modified protein for gene transfer and process for producing the same |
| 01/11/2000 | US6013480 Antagonists of interleukin-15 |
| 01/11/2000 | US6013285 Pumping an albumin protein solution and alcohol solution to first mixing chamber, mixing together to form protein spheres solution, pumping spheres to a second chamber, pumping crossliking agent and crosskinking the protein sphere |
| 01/11/2000 | US6013283 Alkyl or olefinic endcapped polyalkylene oxide solubilizer |
| 01/11/2000 | US6013282 Enteric film coating compositions, method of coating therewith, and coated forms |
| 01/11/2000 | US6013281 Method of making a pharmaceutical dosage form comprising a proton pump inhibitor |
| 01/11/2000 | US6013279 Combination preparation for stimulating the growth of hair and optionally the growth of skin and nails as well as for preventing or eliminating the loss of hair |
| 01/11/2000 | US6013264 Comprising hepatitis b surface antigen (hbsag); stability, efficiency; for immunization against diphtheria, tetanus, pertussis, polio, haemophilus influenzae b, hepatitis a, meningitis a, meningitis b, meningitis c, and otitis media |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/11/2000 | US6013240 Nucleic acid containing composition, preparation and uses of same |
| 01/11/2000 | US6012375 Aircraft infrared guided defense missile system |
| 01/11/2000 | CA2247114C Liquid oral compositions comprising a calcium compound and an acidulant |